甲亢性心脏病的病因研究进展(2)
 |
| 第1页 |
参见附件(274KB，2页)。
[9]冯烈,林智强,杨晶.甲亢性心脏病患者血浆心钠素的检测及其临床意义[J].中国实用内科杂志,1999，19(4)：234-235.
[10]Modzelewska A, Szelachowska M, Zonenberg A, et al. Selected markers of endothelial dysfunction in patients with subclinical and overt hyperthyroidism[J]. Endokrynol Pol, 2006，57(3):202-210.
[11]Danzi S, Klein I. Thyroid hormone and the cardiovascular system[J]. Minerva Endocrinol, 2004,29(3):139-150.
[12]Moolman JA. Thyroid hormone and the heart[J]. Cardiovasc J S Afr, 2002 ,13(4):159-163.
[13]Danzi S, Dubon P, Klein I. Effect of serum triiodothyronine on regulation of cardiac gene expression: role of histone acetylation[J].Am J Physiol Heart Circ Physiol,2005,289:H1506-H1511.
[14]Watanabe H, Washizuka T, Komura S,et al. Genomic and non-genomic regulation of L-type calcium channels in rat ventricle by thyroid hormone[J]. Endocr Res, 2005,31(1):59-70.
[15]Abe A, Yamamoto T,Mlsome M,et al.Thyroid hormone regulates expression of shaker related polassium channel mRNA in rat heart[J]. Biochem Biopys Res Commun,1998,245(1):226-230.
[16]Chen JL, Chiu HW, Tseng YJ,et al. Hyperthyroidism is characterized by both increased sympathetic and decreased vagal modulation of heart rate: evidence from spectral analysis of heart rate variability[J]. Clin Endocrinol (Oxf), 2006 ,64(6):611-616.
[17]Burggraaf J, Tulen JH, Lalezari S, et al. Sympathovagal imbalance in hyperthyroidism[J].Am J Physiol Endocrinol Metab, 2001,281(5-6):190-195.
(收稿日期：2007-04-19)
本文中所涉及到的图表、注解、公式等内容请以PDF格式阅读原文。
[ 上 页 ]
您现在查看是摘要介绍页，详见PDF附件(274KB，2页)。